The iCMLf is sharing a selection of interesting scientific publications on COVID-19 and CML from peer-reviewed journals.

Latest publications on COVID-19 and Cancer/CML

September 2020

• Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19
  Cattaneo C et al. Cancer, September 2020 (epub ahead of print)
  – open access publication
• Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and The Netherland
  Van Doesum J et al. Leukemia, September 2020 – open access publication

August 2020

• Risk factors and outcome of COVID-19 in patients with haematological malignancies
  Piñana JL et al. Exp Hematol Oncol, August 2020 – open access publication
• COVID-19 in haematological malignancy patients: A protocol for a systemic review and meta-analysis
  Chen C et al. Medicine (Baltimore), August 2020 – open access publication
• COVID-19 in children with blood and cancer disorders: What do we know so far?
  Yadar SP. J Pediatr Hematol Oncol, August 2020
• Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
  Basci S et al. J Oncol Pharm Pract, August 2020
• COVID-19 in patients with haematological malignancies: A retrospective case series
  Infante MS et al. Int J Lab Hematol, August 2020 (epub ahead of print)
  – open access publication
• The outcome of COVID-19 in patients with haematological malignancy
  Yigenoglu TN et al. J Med Virol, August 2020 (epub ahead of print)
  – open access publication
• Clinical characteristics and risk factors associated with COVID-10 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
  Passamonti F et al. Lancet Haematol, August 2020 (epub ahead of print)
  – open access publication
• Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-10 inpatients with haematological malignancies
  Wu Y et al. Leuk Lymphoma, August 2020 (epub ahead of print)

July 2020

• SARS CoV2 infection in chronic myelogenous leukemia: Severe haematological presentation
  Sorà F et al. Transfus Apher Sci, July 2020 (epub ahead of print)
  – open access publication
• Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic: A prospective cohort study
  Ector GICG et al. Leukemia, July 2020 (epub ahead of print)
  - open access publication
• Survival study of hospitalized patients with concurrent COVID-19 and haematological malignancies
  Martín-Moro F et al. Br J Haematol, July 2020 – open access publication
• Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies
  Sanchez-Pina JM et al. Eur J Haematol, July 2020 (epub ahead of print)
• COVID-19 in post transplant patients – report of 2 cases
  Huang J et al. Am J Transplant, July 2020 – open access publication

June 2020

• Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King’s College Hospital experience
  Shah V et al. Br J Haematol, June 2020 (epub ahead of print)
  – open access publication
• Haematological cancers and risk of severe COVID-19: Exploration and critical evaluation of the evidence to date
  El-Sharkawi D et al. Br J Haematol, June 2020 (epub ahead of print)
  - open access publication
• Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey
  Breccia M et al. Leukemia, June 2020 (epub ahead of print) - open access publication
• Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukemia
  Ranger A et al. Br J Haematol, June 2020 (epub ahead of print) - open access publication
• Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structural summary of a study protocol for a randomized controlled trial
  Allahyari A et al. Trials, June 2020 – open access publication
• COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
  Lee LYW et al. Lancet, June 2020 – open access publication
• Managing hematology and oncology patients during the COVID-19 pandemic: Interim consensus guidance
  Weinkove R et al. Med J Aust, June 2020 – open access publication
• Janus faced course of COVID-10 infection in patients with hematological malignancies
  Bellmann-Weiler R et al. Eur J Haematol, June 2020 – open access publication
• Managing patients with hematological malignancies during COVID-19 pandemic
  Sahu KK and Cerny J. Expert Rev Hematol, June 2020 (epub ahead of print)
• Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis
  Meng Y et al. Version 2. J Hematol Oncol, June 2020 – open access publication
• A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An international Collaborative Group
  Al-Shamsi HO et al. Oncologist, June 2020 – open access publication

Find more papers on COVID-19 and cancer/CML here

Latest publications on COVID-19

September 2020

• A living WHO guideline on drugs for COVID-19
  Lamontagne F et al. BMJ, September 2020
• Vaccines for COVID-19
  Tregoning JS. Clin Exp Immunol, September 2020 – open access publication

April 2020

• Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory diseases syndrome in Korea
  Ahn JY et al. J Korean Med Sci, April 2020 - open access publication
• Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
  Xu Y et al. Nat Med, April 2020 - open access publication

Find more papers on COVID-19 here